Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19
Coronavirus disease-2019 (COVID-19) pandemic has become a global threat and death tolls are increasing worldwide. The SARS-CoV-2 though shares similarities with SARS-CoV and MERS-CoV, immunopathology of the novel virus is not understood properly. Previous reports from SARS and MERS-CoV documents tha...
Main Authors: | Kumaragurubaran Karthik, Tuticorin Maragatham Alagesan Senthilkumar, Shanmugasundaram Udhayavel, Gopal Dhinakar Raj |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-12-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2020.1796425 |
Similar Items
-
Absence of antibody-dependent enhancement (ADE) of viral infectivity in the epidemic neuropathy in Cuba
by: Maria G. Guzmán, et al.
Published: (1995-08-01) -
Theoretical Explanation for the Rarity of Antibody-Dependent Enhancement of Infection (ADE) in COVID-19
by: Anna E. Boldova, et al.
Published: (2022-09-01) -
Treatment-Emergent Cilgavimab Resistance Was Uncommon in Vaccinated Omicron BA.4/5 Outpatients
by: Cesare Ernesto Maria Gruber, et al.
Published: (2023-10-01) -
Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2
by: Yalong Yang, et al.
Published: (2022-10-01) -
Discordant Antigenic Properties of Soluble and Virion SARS-CoV-2 Spike Proteins
by: Sameer Kumar, et al.
Published: (2024-03-01)